Pfizer and BioNTech to provide an additional 200 million vaccine doses in the EU in 2022

Pharmaceutical company Pfizer and German partner BioNTech announced Monday that they have reached an agreement to provide an additional 200 million doses of their coronavirus vaccine to the European Commission and EU Member States in 2022.

The two companies stressed that the 200 million installments will be added to the 450 million installments already scheduled to be delivered to the bloc countries, under previous agreements.

The new order “will also cover potential vaccines tailored to treat the Omicron variant at no additional cost if a variational vaccine is deemed necessary and then officially licensed,” the two companies said in a joint statement.

Pfizer shares rose 1.8% in pre-conference Wall Street trading, while BioNTech’s share “recorded” gains of more than 3%.

.

Source From: Capital

You may also like

Guardian: Rumors of Fire Pause Agree
World
Flora

Guardian: Rumors of Fire Pause Agree

Information transmitted by Economist correspondent Oliver Carroll on social media is also reproduced by the Guardian on an agreement that